Haemonetics Welcomes New FDA Guidance on Viscoelastic Testing During COVID-19 Pandemic

Author's Avatar
Jan 22, 2021
Article's Main Image

FDA recognizes importance of increased availability of devices such as market leading TEG® hemostasis analyzers

PR Newswire